Geneva, May 7 -- International Clinical Trials Registry received information related to the study (ChiCTR2600123944) titled 'Exploring the role and mechanism of melatonin in treating pediatric traumatic brain injury based on the BNIP3-mediated mitophagy pathway' on May 3.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Xuzhou Children's Hospital
Condition:
Traumatic brain injury
Intervention:
Control group (moderate to severe TBI):Children with moderate to severe TBI received treatments such as monitoring, control of intracranial pressure, analgesia and sedation, and surgery when necessary, in accordance with the diagnosis and treatment guidelines.
MLT group (moderate to severe TBI):Children with moderate ...